[⁶⁸Ga]Ga-PentixaFor | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

851 results for “[⁶⁸Ga]Ga-PentixaFor”

Trials

View all 473 →

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

8 participants · First posted Nov 9, 2023

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

69 participants · First posted Aug 12, 2022

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

1 participants · First posted Feb 3, 2022

Drugs

View all 196 →

68Ga PentixaFor

GA-004

Organizations

Artivion

United States

Inhibikase Therapeutics

United States

MiMedx

United States

News

View all 178 →

Pentixapharm's CXCR4-Targeted Radiopharmaceuticals Show Promise in Primary Aldosteronism and Bladder Cancer

AI-Powered OCT Analysis Enhances Understanding of Geographic Atrophy Progression and Treatment Response

Emerging Therapies Offer Hope for Geographic Atrophy Treatment

Page 1 of 86